SCHEMBL353377

SCHEMBL353377

NC(=O)c1cccc2c(CCc3ccccc3)c(-c3ccc4c(C(N)=O)cccc4c3CCc3ccccc3)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 2/20 0.47
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
RPS6KB1 P23443 3/20 0.40
NSD2 O96028 2/20 0.40
PARP1 P09874 2/20 0.40
PARP2 Q9UGN5 2/20 0.40
AURKA O14965 1/20 0.40
BCAT2 O15382 1/20 0.40
CD38 P28907 1/20 0.39
GPR52 Q9Y2T5 1/20 0.39
ADRA1D P25100 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL352441 0.85 RPS6KB1 (0.46) SIRT2KMT2AALDH1A1KDM4ERPS6KB1
SCHEMBL11901439 0.77 SIRT2 (0.64) SIRT2KMT2AALDH1A1KDM4EPARP1
SCHEMBL353653 0.75 RPS6KB1 (0.46) SIRT2KMT2AALDH1A1KDM4EGAA
SCHEMBL241943 0.75 RPS6KB1 (0.41) KMT2AATMALDH1A1KDM4EGAA
SCHEMBL6135290 0.73 ATM (0.61) KMT2AATMALDH1A1KDM4EGAA
SCHEMBL353488 0.72 BCAT2 (0.53) SIRT2KMT2AATMALDH1A1KDM4E
SCHEMBL27710824 0.71 SIRT2 (0.45) SIRT2ALDH1A1PARP1PARP2BCAT2
SCHEMBL634722 0.71 ATM (0.55) KMT2AATMALDH1A1KDM4EGAA
SCHEMBL940131 0.71 ALDH1A1 (0.60) SIRT2KMT2AALDH1A1KDM4ELMNA
SCHEMBL355055 0.70 CD38 (0.39) KMT2AATMALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120015992-A1 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2012-01-19 US disclosed
US-8039668-B2 Naphthalene-based inhibitors of anti-apoptotic proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015992-A1 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins HAX1, PRDX1, APOL1 SIRT2 2765/4885KMT2A 4720/4885ATM 2397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.